These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 8390288
1. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations. Macmillan CH, Perkins AC, Wastie ML, Leach IH, Morgan DA. Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288 [Abstract] [Full Text] [Related]
2. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma. Vuillez JP, Moro D, Brambilla E, Brichon PY, Ferretti G, Saccavini JC, Brambilla C. Eur J Cancer; 1994 Jun; 30A(8):1089-92. PubMed ID: 7654435 [Abstract] [Full Text] [Related]
3. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies. Kairemo KJ, Aronen HJ, Liewendahl K, Paavonen T, Heikkonen JJ, Virkkunen P, Mäki-Hokkonen H, Karonen SL, Brownell AL, Mäntylä MJ. Acta Oncol; 1993 Jun; 32(7-8):771-8. PubMed ID: 8305225 [Abstract] [Full Text] [Related]
4. Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. Vuillez JP, Moro D, Brichon PY, Rouvier E, Brambilla E, Barbet J, Peltier P, Meyer P, Sarrazin R, Brambilla C. J Nucl Med; 1997 Apr; 38(4):507-11. PubMed ID: 9098191 [Abstract] [Full Text] [Related]
5. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody. Faivre-Chauvet A, Mease RC, Chetanneau A, Bardiès M, Sai-Maurel C, Meinken GE, Srivastava SC, Chatal JF, Gestin JF. Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905 [Abstract] [Full Text] [Related]
6. Imaging lung cancer by scintigraphy with Indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5. Buccheri G, Biggi A, Ferrigno D, D'Angeli B, Vassallo G, Leone A, Taviani M, Comino A. Cancer; 1992 Aug 15; 70(4):749-59. PubMed ID: 1643607 [Abstract] [Full Text] [Related]
7. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5. Riva P, Paganelli G, Callegaro L, Bartoli MG, Turci D, Benini S, Deleide G, Scassellati GA, Viale G, Siccardi AG. Nucl Med Commun; 1988 Aug 15; 9(8):577-89. PubMed ID: 3173916 [Abstract] [Full Text] [Related]
8. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma. Vieira MR, Rodrigues M, Salgado L, Santos R, de Almeida JC, Manoel LO, de Almeida JM. Eur J Surg Oncol; 1993 Jun 15; 19(3):294-9. PubMed ID: 8314389 [Abstract] [Full Text] [Related]
9. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment. Reiners C, Eilles C, Spiegel W, Becker W, Börner W. Nuklearmedizin; 1986 Dec 15; 25(6):227-31. PubMed ID: 3808964 [Abstract] [Full Text] [Related]
10. Immunoscintigraphy of lung cancer using 111In-labelled antiCEA F023C5-F(ab')2 fragments. Torres M, Jiménez-Heffernan A, Valverde A, González FM, Latre JM, Llamas JM, Baamonde C, López-Rubio F, Mateo A. Nucl Med Commun; 1991 Nov 15; 12(11):937-50. PubMed ID: 1661391 [Abstract] [Full Text] [Related]
11. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography. Buccheri G, Biggi A, Ferrigno D, Leone A, Taviani M, Quaranta M. Chest; 1993 Sep 15; 104(3):734-42. PubMed ID: 8365283 [Abstract] [Full Text] [Related]
12. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA. Hertel A, Baum RP, Lorenz M, Baew-Christow T, Encke A, Hör G. Br J Cancer Suppl; 1990 Jul 15; 10():34-6. PubMed ID: 2166552 [Abstract] [Full Text] [Related]
13. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer. Lind P, Smola MG, Lechner P, Ratschek M, Klima G, Költringer P, Steindorfer P, Eber O. Int J Cancer; 1991 Apr 01; 47(6):865-9. PubMed ID: 2010229 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients. Hnatowich DJ, Mardirossian G, Rusckowski M, Roy S, Bushe H, Griffin TW, Brill AB. Nucl Med Commun; 1993 Jan 01; 14(1):52-63. PubMed ID: 8423936 [Abstract] [Full Text] [Related]
15. CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer. Wittig BM, Hach A, Hahn K, Meyer zum Büschenfelde KH, Dippold WG. Eur J Cancer; 1993 Jan 01; 29A(9):1327-9. PubMed ID: 8343279 [Abstract] [Full Text] [Related]
16. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma. Lind P, Lechner P, Arian-Schad K, Klimpfinger M, Cesnik H, Kammerhuber F, Eber O. J Nucl Med; 1991 Jul 01; 32(7):1319-25. PubMed ID: 2066784 [Abstract] [Full Text] [Related]
17. Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer. Buccheri G, Biggi A, Ferrigno D, Quaranta M, Leone A, Vassallo G, Pugno F. Thorax; 1996 Apr 01; 51(4):359-63. PubMed ID: 8733485 [Abstract] [Full Text] [Related]